Trial Condition(s):

Aspirin, Drug Safety, Effects, Longterm

Pharmacy based pharmacoepidemiological observational study with Aspirin protect 100 mg

Bayer Identifier:

12557

ClinicalTrials.gov Identifier:

NCT01669824

EudraCT Number:

Not Available

Study Completed

Trial Purpose

In this non-interventional one year study, data about overall and particularly gastrointestinal tolerability, indications, cardiovascular risk factors and compliance are collected by basic questionnaires, which are handed out by pharmacists to patients who acquire (in Germany no prescription is needed) Rx (Prescription) or OTC (Over-The-counter) Aspirin protect (enteric coated aspirin) 100 mg and are willing to participate in the study. After 3, 6, 9 and 12 months follow-up questionnaires are sent out. Aim of the study is to get information about safety, usage and compliance under everyday's conditions, because in Germany low-dose aspirin is an OTC product with Rx indication.

Inclusion Criteria
No Inclusion Criteria Available
Exclusion Criteria
Inclusion Criteria:
  - Patients who buy Aspirin protect 100 mg in a pharmacy and are willing to participate in the study.

Trial Summary

Enrollment Goal
4235
Trial Dates
black-arrow
Phase
N/A
Could I receive a placebo?
No
Products
Aspirin (Acetylsalicylic Acid, BAYE4465)
Accepts Healthy Volunteers
No

Where to Participate

Loading...
Locations
Status
LocationsStatus
Locations

Investigative Site

Many Locations, Germany

Status
Completed
 

Trial Design